Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

NCT00071409 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Insulin-Dependent

Interventions

DRUG: INGAP-Peptide
DRUG: INGAP-Peptide
DRUG: placebo

Sponsor

Exsulin Corporation